This Centre will promote multidisciplinary care and enable coordinated delivery of the most advanced aortic therapies in the world.
This Centre will further position PMCC as an international leader in the investigation and treatment of heart rhythm disorders.
Furthering PMCC’s foundation of research strengths, this Centre will provide resources to support innovative and ground breaking clinical trials research necessary to evaluate new devices and therapies.
This Centre will lead the way in ‘personalized’ patient care by integrating traditional clinical information with genetics, molecular, cellular and physiological data.
This Centre will expand on a collaborative program focused on maintaining and strengthening PMCC’s valve program on the international stage.
This Centre will strive to be one of the world’s leading research and educational programs in heart failure, with a focus on fellowship training and research in outcomes and mechanisms of heart disease.
The Centre of Excellence in Adult Congenital Heart Disease will be at the forefront of clinical and research work, including: surgical and non-surgical intervention, patient education, professional counseling, diagnostics and imaging, evaluation for transplant operations, specialized care for higher risk patients during pregnancy and childbirth, and clinical trials.
The Centre of Excellence in Cardiac Rehab will allow patients to better understand their heart condition and risk factors, along with the importance of a healthy lifestyle through an initial group orientation and education session.